High levels of PGC1α are associated with a poorer prognosis in metastatic melanoma (65, 76) since melanoma with high PGC-1α expression has a higher mitochondrial biosynthetic capacity (71, 104). Here, PPARGC1A is linked to metastatic melanoma.